Drug Genius
368 posts
Drug Genius Staff Writer
Posts By Drug Genius
Arbutus to Present at UBS Virtual Global Healthcare Conference
WARMINSTER, Pa., May 12, 2020 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company focused on developing a cure for people with…
Share
Catalyst Pharmaceuticals Announces First Quarter 2020 Financial Results and Provides Corporate Update
Firdapse® Q1 2020 Net Revenues of $29.1 MillionFirst Quarter 2020 GAAP Net Income of $10.4 MillionCatalyst Withdraws Previous 2020 Revenue Guidance Due to COVID-19 UncertaintiesCatalyst to…
Share
Novavax Reports First Quarter 2020 Financial Results
CEPI increases investment up to $388 million for NVX‑CoV2373 vaccine development & manufacturingNVX‑CoV2373 Phase I trial initiating in May with preliminary results in JulyNanoFlu…
Share
Novavax to Receive up to $388 Million Funding from CEPI for COVID-19 Vaccine Development and Manufacturing
Funds clinical development of NVX-CoV2373 through Phase 2Supports rapid scale-up of vaccine manufacturingAllows for increased production of Matrix-M adjuvantReserves global large-scale…
Share
Liquidia Reports First Quarter 2020 Financial Results and Provides Corporate Update
Received FDA Acceptance of LIQ861 NDA for ReviewReported Final Safety and Tolerability Results for LIQ861 Inspire TrialManagement to Host Webcast and Conference Call Today at 4:30p.m…
Share
Novavax to Present COVID-19 Vaccine Candidate Progress in World Vaccine Congress Webinar Series
GAITHERSBURG, Md., May 11, 2020 (GLOBE NEWSWIRE) — Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases…
Share
Onconova Therapeutics Announces Virtual Format for 2020 Annual Meeting of Stockholders
NEWTOWN, Pa., May 11, 2020 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to…
Share
Ritter Pharmaceuticals Regains Compliance with Nasdaq’s Stockholders’ Equity Requirement for Continued Listing
LOS ANGELES, May 11, 2020 (GLOBE NEWSWIRE) — Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), today announced that it has received written notice…
Share
Myriad Receives FDA Approval of myChoice CDx® as Companion Diagnostic for Lynparza™ (olaparib) In Patients with Advanced Ovarian Cancer
SALT LAKE CITY, May 11, 2020 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, today announced that the U.S. Food and Drug…
Share
Arbutus Reports First Quarter 2020 Financial Results, Provides Pipeline Update and Announces New Research Initiative to Identify Novel Antiviral Therapies for the Treatment of Coronavirus Infections
Arbutus remains on track to achieve its key 2020 objectives despite COVID-19 challengesConference Call and Webcast Scheduled Today at 8:00 AM ETWARMINSTER, Pa., May 11, 2020 (GLOBE…
Share